Evidence map›Paper›PMID 41152259›Full record

ArticleScientific reports2025

Enriched lung cancer classification approach using an optimized hybrid deep learning approach.

M Naveenraj, P Vijayakumar

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M NaveenrajDepartment of Computer Science and Engineering (IOT and CS with BCT), SNS College of Engineering, Coimbatore, Tamilnadu, India. naveenrajm055@gmail.com.
P VijayakumarDepartment of Electronics and Communication Engineering, PSG Institute of Technology and Applied Research, Coimbatore, Tamilnadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains one of the deadliest diseases in the world and early detection is critical to enhancing survival rates. With traditional diagnostic techniques - CT scans and chest X-rays - an invasive procedure must be performed and, in some cases, it relies on expert interpretation. Whether benign or malignant, the similarities in visual characteristics of nodules leads to ambiguity and makes for a difficult case which calls for the development of automatic lung cancer classification framework such as the one we proposed, which incorporates Deep Learning (DL) methods and uses a rigourous training methodology on top of that. Our framework pre-processes the images with adaptive filters to eliminate noise, segments lesions, removes, and refines features with Hybrid Horse Herd Optimization (HHO) and Lion Optimization Algorithm (LOA). Those features are classified with a hybrid Deep Convolutional Neural Network and Long Short-Term Memory (DCNN + LSTM) model, which jointly enhances features extraction and temporal learning. We run data learning against standard lung CT datasets and achieved a score of 98.75% accuracy, demonstrating the proposed system is effective in classifying normal lung tissue from abnormal. Nonetheless, the real-time usability of the system is limited by the performance of the CT, and the computational demands of the model, which can be troublesome for clinical situations that typically possess less computational power. Furthermore, these limitations never the less provide a more intelligent, accurate diagnostic aid for radiologists that non-invasively assists in clinical decision making and, importantly, earlier cancer diagnoses.

Indexed as

Deep LearningLung NeoplasmsAlgorithmsHumansNeural Networks, ComputerTomography, X-Ray ComputedClassificationDeep learningHorse herd optimizationHybrid optimizationLion optimization algorithmLung CancerPre-ProcessingSegmentation

Identifiers

PMID41152259
PMCPMC12569064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.